A consensus statement for safety monitoring guidelines of treatments for major depressive disorder
- PMID: 21888608
- PMCID: PMC3190838
- DOI: 10.3109/00048674.2011.595686
A consensus statement for safety monitoring guidelines of treatments for major depressive disorder
Abstract
Objective: This paper aims to present an overview of screening and safety considerations for the treatment of clinical depressive disorders and make recommendations for safety monitoring.
Method: Data were sourced by a literature search using MEDLINE and a manual search of scientific journals to identify relevant articles. Draft guidelines were prepared and serially revised in an iterative manner until all co-authors gave final approval of content.
Results: Screening and monitoring can detect medical causes of depression. Specific adverse effects associated with antidepressant treatments may be reduced or identified earlier by baseline screening and agent-specific monitoring after commencing treatment.
Conclusion: The adoption of safety monitoring guidelines when treating clinical depression is likely to improve overall physical health status and treatment outcome. It is important to implement these guidelines in the routine management of clinical depression.
Similar articles
-
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.World J Biol Psychiatry. 2018 Aug;19(5):330-348. doi: 10.1080/15622975.2017.1379609. Epub 2017 Oct 6. World J Biol Psychiatry. 2018. PMID: 28984491 Review.
-
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.Can J Psychiatry. 2016 Sep;61(9):540-60. doi: 10.1177/0706743716659417. Epub 2016 Aug 2. Can J Psychiatry. 2016. PMID: 27486148 Free PMC article. Review.
-
[Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].Encephale. 2017 Feb;43(1):62-68. doi: 10.1016/j.encep.2016.02.017. Epub 2016 Jul 21. Encephale. 2017. PMID: 27452149 Review. French.
-
The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.Brain Stimul. 2016 May-Jun;9(3):336-346. doi: 10.1016/j.brs.2016.03.010. Epub 2016 Mar 16. Brain Stimul. 2016. PMID: 27090022 Free PMC article. Review.
-
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Aust N Z J Psychiatry. 2015 Dec;49(12):1087-206. doi: 10.1177/0004867415617657. Aust N Z J Psychiatry. 2015. PMID: 26643054 Review.
Cited by
-
Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review.EClinicalMedicine. 2024 Mar 13;70:102507. doi: 10.1016/j.eclinm.2024.102507. eCollection 2024 Apr. EClinicalMedicine. 2024. PMID: 38516102 Free PMC article.
-
Statins and Antidepressants: A Comprehensive Review and Clinical Outlook of the Risks and Benefits of Co-prescription (2022).Cureus. 2022 Dec 8;14(12):e32331. doi: 10.7759/cureus.32331. eCollection 2022 Dec. Cureus. 2022. PMID: 36632257 Free PMC article. Review.
-
The Anti-Depressant Effects of Statins in Patients With Major Depression Post-Myocardial Infarction: An Updated Review 2022.Cureus. 2022 Dec 8;14(12):e32323. doi: 10.7759/cureus.32323. eCollection 2022 Dec. Cureus. 2022. PMID: 36628002 Free PMC article. Review.
-
The Significance of Sleep Disorders in Post-myocardial Infarction Depression.Cureus. 2022 Oct 31;14(10):e30899. doi: 10.7759/cureus.30899. eCollection 2022 Oct. Cureus. 2022. PMID: 36465738 Free PMC article. Review.
-
The Risk of Fatal Arrhythmias in Post-Myocardial Infarction Depression in Association With Venlafaxine.Cureus. 2022 Sep 13;14(9):e29107. doi: 10.7759/cureus.29107. eCollection 2022 Sep. Cureus. 2022. PMID: 36258960 Free PMC article. Review.
References
-
- Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289:3095–3105. - PubMed
-
- Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15:357–376. - PubMed
-
- Slade T, Johnston A, Oakley Browne MA, Andrews G, Whiteford H. 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry. 2009;43:594–605. - PubMed
-
- Worthy KC, Governale LA. Trends in outpatient prescription usage in the U.S., 2002 - 2005. Poster presented at the 12th Annual FDA Science Forum; April 18-20, 2006; Washington, DC. board no. 1-13.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical